Phages as Therapeutic Tools Against Multidrug Resistant Bacteria (AAC ed.)

<p>Bacteriophages are interesting viruses that target bacteria and have been used for therapeutic purposes. Recently, the emergence of antibiotic resistance has spurred a renewed interest in using these viruses or their products as therapeutic tools against recalcitrant human pathogens. AAC has also published a recent manuscript from ARLG to guide the use of phages in clinical practice. We will discuss with experts in the field the state-of-the-art in phage therapy.</p> <p>Objectives:</p> <p>• Understand the use of bacteriophages and their products for therapeutic purposes<br /> • Discuss the clinical applications of phages<br /> • Debate the barriers for developing of phages as therapeutic tools to treat multidrug-resistant infections</p> <p>Guests:</p> <p>• Vincent A. Fischetti, Ph.D, Professor and Director, Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY.<br /> • Saima Aslam, MBBS, Professor of Medicine, University of California San Diego, San Diego, CA.<br /> • Anthony Maresso, PhD. Professor and Founder of TAILOR Labs, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX.</p> <p>This episode of Editors in Conversation is brought to you by the Antimicrobial Agents and Chemotherapy Journal and hosted by AAC Editor in Chief, Cesar Arias. AAC is available at <a href= "https://asm.org/aac" target="_blank" rel= "noopener">https://asm.org/aac</a>. Follow Cesar on twitter at <a href="https://twitter.com/SuperBugDoc" target="_blank" rel= "noopener">https://twitter.com/SuperBugDoc</a> for AAC updates.</p> <p>Subscribe to the podcast at <a href="https://asm.org/eic" target="_blank" rel="noopener">https://asm.org/eic</a></p>